GeoVax Labs Earnings Estimate

GOVX Stock  USD 2.70  0.31  10.30%   
By analyzing GeoVax Labs' earnings estimates, investors can diagnose different trends across GeoVax Labs' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for GeoVax Labs is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
GeoVax Labs is projected to generate 0.0 in earnings per share on the 31st of December 2025. GeoVax Labs earnings estimates module stress-tests analyst consensus about projected GeoVax Labs EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as GeoVax Labs, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing GeoVax Labs' earnings estimates, investors can diagnose different trends across GeoVax Labs' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit Margin is likely to rise to 0.37 in 2024, despite the fact that Gross Profit is likely to grow to (19.7 M).
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GeoVax Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

GeoVax Labs Earnings per Share Projection vs Actual

About GeoVax Labs Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of GeoVax Labs earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current GeoVax Labs estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as GeoVax Labs fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-104.4 M-99.1 M
Retained Earnings Total Equity-41.2 M-43.3 M
Earnings Yield(1.89)(1.79)
Price Earnings Ratio(0.53)(0.56)
Price Earnings To Growth Ratio(0.01)(0.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.